Latest news
Loading news…
Syntis Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Boston, Massachusetts, United States Founded 2022 11-50 employees For Profit
Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 26
- IT spend
- $124K
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 57
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.3
- Trend (30d)
- -0.6
- Trend (90d)
- -1.2
- Last leadership hire
- Jun 9, 2026
Key People at Syntis Bio
Chief Development Officer
Co-Founder, President, Chief Executive Officer
Chief Financial Officer
Chief Business Officer
6
professional contacts at Syntis Bio
Contact execs at Syntis Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Syntis Bio
Loading news…
FAQs about Syntis Bio
People who checked this page also checked these
Browse the full Acquirezy directory.